Literature DB >> 13654527

Studies of the uricogenic effect of 2-substituted thiadiazoles in man.

I H KRAKOFF, M E BALIS.   

Abstract

Entities:  

Keywords:  THIAZOLES/effects; URIC ACID/in urine

Mesh：

Substances：

Year:  1959        PMID： 13654527      PMCID： PMC293241          DOI： 10.1172/JCI103873

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  Overproduction of uric acid as the cause of hyperuricemia in primary gout.

Authors:  J B WYNGAARDEN
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

2.  Comparison of teratogenic chemicals in the rat and chick embryos; an exhibit with additions for publication.

Authors:  M L MURPHY; C P DAGG; D A KARNOFSKY
Journal:  Pediatrics       Date:  1957-04       Impact factor: 7.124

3.  Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo.

Authors:  B LEVENBERG; I MELNICK; J M BUCHANAN
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

4.  Simple microdetermination of uric acid.

Authors:  C A DUBBS; F W DAVIS; W S ADAMS
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

5.  The occurrence of hyperuricemia during pyrazinamide-isoniazid therapy.

Authors:  J H CULLEN; L J EARLY; J M FIORE
Journal:  Am Rev Tuberc       Date:  1956-08

6.  Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors.

Authors:  H J KELLY; H E SKIPPER; A J TOMISEK
Journal:  Arch Biochem Biophys       Date:  1956-10       Impact factor: 4.013

7.  Effects of 2-ethylamino-1, 3, 4 thiadiazole HCI on uric acid production in man.

Authors:  I H KRAKOFF; G B MAGILL
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

8.  Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).

Authors:  I H KRAKOFF; D A KARNOFSKY
Journal:  Am J Physiol       Date:  1958-10

9.  Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease.

Authors:  G B MAGILL; W P MYERS; H C REILLY; R C PUTNAM; J W MAGILL; M P SYKES; G C ESCHER; D A KARNOFSKY; J H BURCHENAL
Journal:  Cancer       Date:  1957 Nov-Dec       Impact factor: 6.860

10.  Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease.

Authors:  R R ELLISON; D A KARNOFSKY; S S STERNBERG; M L MURPHY; J H BURCHENAL
Journal:  Cancer       Date:  1954-07       Impact factor: 6.860
View more
  9 in total

1.  A study of the hyperuricemia induced by hydrochlorothiazide and acetazolamide separately and in combination.

Authors:  J H AYVAZIAN; L F AYVAZIAN
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

2.  Suppression of uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine.

Authors:  A I GRAYZEL; J E SEEGMILLER; E LOVE
Journal:  J Clin Invest       Date:  1960-03       Impact factor: 14.808

Review 3.  Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.

Authors:  J E Seegmiller
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

4.  Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.

Authors:  D Raghavan; J Bishop; D Sampson; J Grygiel; R Woods; A Coates; R Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.

Authors:  P J Elson; L K Kvols; S E Vogl; D J Glover; R G Hahn; D L Trump; P P Carbone; J D Earle; T E Davis
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

Review 6.  Aminothiadiazoles.

Authors:  D L Hill
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

7.  The pharmacologic fate of the antitumor agent 2-amino-1,3,4-thiadiazole in the dog.

Authors:  K Lu; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

8.  Clinical and clinical pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728).

Authors:  J A Stewart; C C Ackerly; C F Myers; R A Newman; I H Krakoff
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Pyrimidine metabolism in man. V. The measurement in vivo of the biochemical effect of antineoplastic agents in animal and human subjects.

Authors:  M T RABKIN; E W FREDERICK; M LOTZ; L H SMITH
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.